Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cosmos Health (COSM) Assets (2016 - 2025)

Cosmos Health's Assets history spans 13 years, with the latest figure at $65.5 million for Q4 2025.

  • Quarterly results put Assets at $65.5 million for Q4 2025, up 20.56% from a year ago — trailing twelve months through Dec 2025 was $65.5 million (up 20.56% YoY), and the annual figure for FY2025 was $65.5 million, up 20.56%.
  • Assets for Q4 2025 was $65.5 million at Cosmos Health, down from $69.5 million in the prior quarter.
  • In the past five years, Assets ranged from a high of $71.5 million in Q3 2023 to a low of $41.7 million in Q1 2021.
  • The 5-year median for Assets is $61.3 million (2024), against an average of $58.3 million.
  • The sharpest move saw Assets soared 77.64% in 2021, then fell 17.73% in 2024.
  • Year by year, Assets stood at $49.4 million in 2021, then skyrocketed by 37.65% to $68.0 million in 2022, then decreased by 2.97% to $66.0 million in 2023, then fell by 17.73% to $54.3 million in 2024, then rose by 20.56% to $65.5 million in 2025.
  • According to Business Quant data, Assets over the past three periods came in at $65.5 million, $69.5 million, and $61.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.